Why the study?
Can a multi-signal device analyzing non-invasive surrogate measures estimate Cardiac Output and Systemic Vascular Resistance for home-based management of CHF patients?
Can a multi-signal device analyzing non-invasive surrogate measures estimate Cardiac Output and Systemic Vascular Resistance for home-based management of CHF patients?
Answers are grounded in this paper and cite their sources.
A novel multi-signal device concept for home-based CHF management aims to estimate cardiac output and systemic vascular resistance using non-invasive surrogate measures.
State-of-the-Art disease management for Congestive Heart Failure (CHF) patients is still based on easy-to-acquire measures such as heart rate (HR), weight and blood pressure (BP). However, these measures respond late to changes of the patient health status and provide limited information to personalize and adapt medication therapy. This paper describes our concept called "Cardiac Status Assessment" we have been investigating within the European project "HeartCycle" towards next-generation home-based disease management of CHF. In our concept we analyze non-invasive surrogate measures of the cardio-vascular function in particular systolic time intervals and pulse wave characteristics to estimate Cardiac Output (CO) and Systemic Vascular Resistance (SVR) both are established clinical measures. We discuss the underlying concept, a developed measurement system and first results.
No takes yet. Share an insight, caveat, or question.
Muehlsteff et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: